1D1 Flashcards
IV abbreviation
intravenous
IM abbreviation
intramuscular
SC abbreviation
subcutaneous
what are the barriers that the drug can pass
GI tract - enteral
IV - parental “around GI”
BSA equation
square root (ht*wt/3600)
inches to cm
2.54 cm/in
lbs to kg
1kg/2.2lbs
what is the full flow in adults
50 cc/kg
what is the full flow in neonates
150 cc/kg
what is the CI full flow for adults
2.4
what is the CI full flow for neonates
2.6-3.0
what is pharmacokinetics
what the body does to a drug
refers to the movement of drug into, through, and out of the body
pharmacokinetics is the time course of its
absorption, bioavailability, distribution, metabolism, and excretion
what is pharmacodynamics
what a drug does to the body
the relationship b/w drug concentration at the site of action and the resulting effect
what does pharmacodynamics involve
receptors, binding, post receptor effects, and chemical interactions
the effect of a drug present at the site of action is determined by
that drug’s binding with a. receptor
what is drug absorption
is the transfer of a drug from the site of administration to systemic circulation.
the main factor that relates to absorption is
the route the drug enters the body
it come in contact w/ several membranes. Drugs pass some membranes but not others
Two major routes of administration
– Enteral: Administration by mouth, enters through mucosal membrane
– Parenteral: Administration of a drug directly into systemic circulation or vascular tissue
Physiological considerations in absorption are :
– blood flow
– total surface area
– time of arrival of the drug and time of drug at absorption site.
Other considerations for absorption are
solubility, chemical stability and how soluble the drug is in lipids
Enteral Administration (PO)
Oral Administration, Sublingual, Buccal, and Rectal
advantages of enteral admin
Can be self administered and over-dose can be over come by antidote (activated charcoal).
disadvantages of enteral admin
Drugs absorbed in the GI tract enter portal (hepatic) circulation before being distributed into systemic circulation. These drugs will undergo first pass metabolism in the liver which limits the efficacy of the drug. First pass metabolism decreases the amount of drug that enters systemic circulation.
Parenteral
direct delivery of drugs into systemic circulation
what are some examples of parenteral delivery
– Intramuscular (IM) Lipid based drugs are absorbed slowly and aqueous based drugs are absorbed rapidly. – Intravascular (IV) – Subcutaneous (SC) – Intrathecal (IT) – Intraperitoneal (IP) – Intradermal (ID) – Inhalation
advantages of parenteral delivery
Provides rapid onset of pharmacologic effect and maximum control over circulating levels of drug. A
disadvantages of parenteral delivery
Unlike drugs administered via the GI tract, drugs given IV cannot be recalled by strategies like emesis or binding to activated charcoal. Requires specialized training to gain IV access. Potential risk of systemic infection from IV site.
Bioavailability
is a subcategory of absorption and is the fraction (%) of an administered drug that reaches the systemic circulation
if 100 mg of a drug is given and 70 mg are absorbed unchanged into systemic circulation, what is the bioavailability
0.7 or 70 %.
Factors that influence bioavailability include:
irst pass hepatic metabolism
– Solubility of the drug!
fat is very hydrophilic drugs are poorly absorbed because
they cannot pass through lipid dense cell membranes.
Extremely hydrophobic drugs are also poorly absorbed because
the are insoluble in aqueous body fluids.
what drugs are absorbed most readily
small non-ionized lipid soluble drugs
drug associated factors
- passive diffusion
- facililtated diffusion
- aqueous channels
- active transport
Passive diffusion:
fast for lipophilic, nonionic and small molecules. Slow for hydrophilic Ionics, or large molecules
Facilitated diffusion
is the process of spontaneous passive transport of molecules or ions across a biological membrane via specific transmembrane integral proteins
Chemically similar drugs compete for a carrier
Aqueous Channels
Small hydrophilic drugs diffuse by concentration gradients (high»_space;>low) thru aqueous pores.
Active transport:
Same as facilitated diffusion except that ATP powered drug transport against concentration gradient (low»high)
Patient-associated factors that affect drug absorption
– food in GI tract
– renal disease
– liver disease
Drug Distribution
drug leaves the bloodstream and enters the extra-cellular fluid and or cells of tissue.
Drugs are distributed into
major body fluids
Delivery of a drug to the extra-cellular fluid depends on: (4)
- blood flow
- capillary permeability: membrane permeability
- degree of protein binding to plasma proteins
- relative solubility of the drug
Some drugs can not cross the blood-brain barrier therefore
they will not work in the brain
what are some barriers the drug must break thru
blood brain barrier
blood-placenta barrier
blood-testes barrier
the binding of drugs to proteins such as albumin results
in less drugs free (not bound) in the blood available to enter the target organ.
Depot Storage
a body area in which a substance, e.g., a drug, can be accumulated, deposited, or stored and from which it can be distributed
Lipophilic drugs get stored and accumulate in
fat
these drugs are released slowly from fat stores
calcium binding drugs accumulate in
teeth and bone
heparin is heavily bound to
proteins
Volume of distribution (Vd ):
calculated value of volume that would be required to contain the d
administered dose that was evenly distributed at the concentration measured in plasma.
if the Vd = 3 liters, where does it get distributed to?
distributed in plasma only (plasma volume = 3 liters).
Vd = 16 liters is likely distributed in
extracellular water (3L+13L)
Vd >46 liters is likely sequestered in
a depot because the body only contains 40-46 liters of fluid.
In general, drugs with a short T1/2 have
a small VD and rapid clearance
Drugs with a long T1/2 (lipid soluble) have
a larger VD and slower elimination rate.
Drug Metabolism
the biotransformation process of making a drug more polar and water soluble
Biotransformation occurs mainly in
the liver and is therefore often called hepatic metabolism.
Metabolic reactions can transform
– An active drug into less-active or inactive forms
– a PRODRUG (inactive or less-active drug) into a more active drug (Plavix)
drug metabolism is split into what two phase
- phase 1 (non-synthetic)
- phase 2 (synthetic)
phase 1 of drug metabolism is when
drugs oxidized or reduced to a more polar form
what is an example of phase 1 drug metabolism
Cytochrome P450 (liver microsomal) drug oxidation, reduction and hydrolysis
phase 2 of drug metabolism is when
a polar group is conjugated to the drug
this increase the clarity of the drug
Drugs undergoing phase II reactions may have already undergone
Phase 1
what is an example of phase 2 drug metabolism
glutathione
Drug Excretion
the elimination of the un-metabolized drug and its metabolites from the body
most drugs are excreted in
urine via active glomerular filtration
-others in feces or expired air
what is enters-hepatic ciruclation
when drugs are excreted in the feces, the bile may become concentrated before entering into the intestines
this can extend the duration of the drug in the body
Drug excretion in the urine is affected by
Glomerular filtration
Tubular Secretion
Tubular Reabsorption
Because drugs, metabolites, and toxins are concentrated in the kidney, the kidney is at risk for what
chemical induced toxicity
-renal failure patients may be due to drug accumulation
drug clearance
Volume of fluid that would be completley cleared of drug per unit time
- can be directly measured in the body
- calculated value in liters/hr
clearance equation
Elimination rate (mg/hr)/ Drug Concentration (mg/L)
Elimination half-time (t 1/2)
time necessary for plasma concentration to decrease by 50%.
- shortened with small Vd and rapid clearance
- Prolonged with high lipid solubility and large Vd.
Zero order kinetics
rate of elimination is constant, independent of drug concentration (i.e. alcohol, phenytoin, salicylates)
First order kinetics
rate of elimination occurs dependent of drug concentration
- the higher the t1/2, the less percentage of drug remains
if the t 1/2 = 1, how much remains
1/2
if t 1/2 = 5, how much remains?
3.125%